Literature DB >> 18384550

Rifampicin in the treatment of psoriasis.

N Tsankov, I Grozdev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18384550     DOI： 10.1111/j.1468-3083.2008.02721.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

Review 1.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

Review 2.  The pregnane X receptor in tuberculosis therapeutics.

Authors:  Amina I Shehu; Guangming Li; Wen Xie; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-05       Impact factor: 4.481

3.  Fluorescent imaging for assessment of the effect of combined application of electroporation and rifampicin on HaCaT cells as a new therapeutic approach for psoriasis.

Authors:  Biliana Nikolova; Anelia Kostadinova; Borislav Dimitrov; Zhivko Zhelev; Rumiana Bakalova; Ichio Aoki; Tsuneo Saga; Iana Tsoneva
Journal:  Sensors (Basel)       Date:  2013-03-14       Impact factor: 3.576

4.  Antistreptococcal interventions for guttate and chronic plaque psoriasis.

Authors:  Gwendy Dupire; Catherine Droitcourt; Carolyn Hughes; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2019-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.